| Literature DB >> 23256921 |
Hugo Olmedillas1, Alejandro González-Agüero, Luis A Moreno, José A Casajus, Germán Vicente-Rodríguez.
Abstract
BACKGROUND: Cycling is considered to be a highly beneficial sport for significantly enhancing cardiovascular fitness in individuals, yet studies show little or no corresponding improvements in bone mass.Entities:
Mesh:
Year: 2012 PMID: 23256921 PMCID: PMC3554602 DOI: 10.1186/1741-7015-10-168
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Figure 1Flow chart diagram of the study selection process.
Studies concerning bone mass, bone metabolism and cycling participation
| Study | Participants | Exercise | Years of cycling training | Study design | Data source | Resultsa | Strength of evidence | ||
|---|---|---|---|---|---|---|---|---|---|
| Number | Sex | Age | |||||||
| Barry | CYC (20) | M | 22 to 45 | Competitive level | 2-h exercise bout at 60% to 75% VT | Hormones, calcium | Parathyroid was increased after 2 h of cycling. | B: observational | |
| Barry | CYC (14) | M | 27 to 44 | >450 h/year | 4.9 ± 2.4 | Two groups: HIGH and LOW calcium supplementation over 1-year season | DXA | Both groups decreased BMD over 1 year in total hip and subregions, without differences for HIGH or LOW calcium. | A: RCT |
| Barry | CYC and TRI (20) | M | 37 ± 7.6 | - | 6.0 ± 6.5 | Different calcium supplementation groups over three 35-km trials | DXA, hormones | 30% of participants had LS BMD T-score over -1.0. Calcium supplementation attenuates disruption of parathyroid hormone. | A: RCT |
| Beshgetoor | CYC (12); RUN (9); CON (9) | F | 49.6 ± 7.9 | - | - | 18 months follow-up | DXA, calcium intake | Femur BMD maintained in CYC and RUN, decline CON. LS BMD maintained RUN, decline CYC and CON. No relationship between BMD and calcium intake. | B: case-control |
| Brown | CYC (32) | M/F | 16 to 62 | Competitive cycling | >2 | Two groups: HIGH FAT and HIGH CARBOHYDRATE intake; 12-week intervention | DXA | No differences in fat or lean accumulation between groups. BMD increased in HIGH FAT group. | A: RCT |
| Campion | CYC (30) | M | 29 ± 3.4 | 22 to 25 h/week | - | Cross-sectional | DXA | CYC lower WB, LS, pelvis, femoral neck, upper and lower limbs than CON | B: case-control |
| Duncan | CYC (15) | F | 16 to 17 | ≥8 h/week | 3.1 ± 1.8 | Cross-sectional | DXA | CYC lower legs BMD than RUN. No differences with CON. | B: case-control |
| Duncan | CYC (10) | F | 16 to 17 | ≥8 h/week | 3.1 ± 1.8 | Cross-sectional | MRI, DXA | CYC lower cortical CSA, moment of inertia and mid-femur BMD than RUN. No differences with CON. | B: case-control |
| Fiore | CYC (14); CAN (18); CON (28) | M | - | - | - | Cross-sectional | DXA | CYC lower WB, LS and pelvic BMD than CAN. No differences with CON. | B: case-control |
| Guillaume | CYC (29) | M | 26.5 ± 5.3 | 25,000 to 30,000 km/year | 4.5 ± 4 | Descriptive | DXA, bone markers | CYC lower LS BMD Z-scores. Bone turnover markers were in a normal range. | B: case series |
| Heinonen | CYC (22); ORI (30); SKI (28); CYC (29); WL (18); CON (25) | F | 18 to 32 | - | - | Cross-sectional | DXA, calcium intake | CYC lower BMD at all sites than WL. No differences with CON. No relationship between BMD and calcium intake. | B: case-control |
| Hinrichs | CYC (16) | M/F | 17 to 30 | 15 h/week | >4 | Cross-sectional | DXA | CYC low values of LS and femur BMD than the other groups | B: case-control |
| Maïmoun | CYC (11) | M | 18 to 39 | 10.6 h/week | - | Cross-sectional | DXA, hormones | CYC and TRI induce androgen deficiency compared to CON, without alteration in BMD | B: case-control |
| Maïmoun | CYC (11) | M | 18 to 39 | 10.6 h/week | 9.3 ± 6.8 | Cross-sectional | DXA, bone markers, calcium intake | CYC lower BAP than all groups. No differences in BMD. No relationship between BMD and calcium intake. | B: case-control |
| Medelli | CYC (73) | M | 25.8 ± 4.3 | ≥3 to 6 h/day | - | Cross-sectional | DXA, calcium intake | CYC had higher calcium intake and lower LS and femoral neck BMD than CON. | B: case-control |
| Medelli | CYC (23) | M | 28.5 ± 3.9 | ≥3 to 6 h/day | - | Descriptive | DXA | Two-thirds of participants had lower values of LS BMD | B: case series |
| Morel | CYC (47); other sports (657) | M | 30 | 7 h/week | - | Cross-sectional. Sportsmen classed as amateur when 11 to 18 years old. | DXA | No differences between different sports | B: case-control, retrospective |
| Nevill | CYC (16) | M | 28.6 ± 6 | >4 h/week | >3 | Cross-sectional | DXA | CYC had no differences in BMD compared to CON, as other sports do | B: case-control |
| Nichols | Young CYC (16) | M | 31.7 ± 3.5 | ≥10 h/week | 10.9 ± 3.2 | Cross-sectional | DXA | Master CYC lower WB BMD than young CYC. Master CYC lower LS and hip BMD than young CYC and CON. | B: case-control |
| Nichols | CYC (19) | M | 50.7 ± 4 | 11.1 h/week | 27.5 ± 6.8 | Longitudinal, 7-year follow-up | DXA | Higher percentage of CYC osteopenic/osteoporotic than CON. Greater increment in this percentage in CYC. | B: case-control |
| Nikander | CYC (29) | F | 20 to 30 | 10.2 ± 6.8 | 5.9 ± 3.1 | Cross-sectional | DXA, calcium intake | CYC and SWI no differences with CON in BMD and CSA, as the rest of the sports. No differences in calcium intake. | B: case-control |
| Olmedillas | CYC (21) | M | 15 to 21 | 10 h/week | 2 to 7 | Cross-sectional | DXA | CYC lower BMC at WB, pelvis, FN and legs, and lower BMD at pelvis, hip and legs. Greater differences in CYC over 17 years compared to CON. | B: case-control |
| Penteado | CYC (31) | M | 24 | 21 h/week | 5.2 ± 3.3 | Cross-sectional | DXA | No differences with CON. | B: case-control |
| Rector | CYC (27) | M | 20 to 39 | ≥6 h/week | >2 | Cross-sectional | DXA, bone markers | CYC lower WB and LS BMD, and 7 times more likely to have osteopenia than RUN. No differences in bone turnover markers. | B: case-control |
| Rico | CYC (22) | M | 16 | ≥10 h/week | >2 | Cross-sectional | DXA, calcium intake | CYC lower legs BMC than CON, without adjustment. No differences when adjusting by weight. No relationship between BMD and calcium intake. | B: case-control |
| Rico | CYC (22) | M | 16 | ≥10 h/week | >2 | Cross-sectional | DXA | CYC lower WB BMC and BMD than CON | B: case-control |
| Sabo | CYC (6) | M | 21 to 24 | 3,000 to 10,000 km in pre-competition | - | Cross-sectional | DXA | CYC lower LS BMD than CON | B: case-control |
| Stewart | CYC (14) | M | 18 to 43 | 8.7 h/week | >2 | Cross-sectional | DXA | CYC lower LS BMD than CON. RUN higher WB BMD than CON. RUN+CYC higher WB BMD than CON. | B: case-control |
| Smathers | CYC (32) | M | 20 to 45 | ≥1 year | 9.4 ± 1.1 | Cross-sectional | DXA, calcium intake, hormones | CYC higher calcium intake. No differences for testosterone. CYC lower LS BMD than CON. | B: case-control |
| Warner | Cross-country CYC (16) | M | 20 to 40 | ≥10 h/week | 5.9 ± 2.8 | Cross-sectional | DXA, hormones | Cross-country CYC higher BMD at all sites that road CYC and CON. No differences in testosterone levels. | B: case-control |
| Wilks | Sprint CYC (52) | M/F | 30 to 82 | <2 h/week | 26 ± 15 | Cross-sectional | pQCT | Sprint CYC higher index of strength in tibia and radius than CON. Distance CYC higher tibial BMC than CON. | B: case-control |
aUnless stated, the results indicate significant differences between two or more groups.
AER = step aerobicists; BAP = bone alkaline phosphatase; BMC = bone mineral content; BMD = bone mineral density; BOX = boxers; CAN = canoeists; CIC = cyclists; CON = controls; CRO = cross-country skiers; CTX = C-terminal collagen crosslinks; DXA = dual energy X-ray absorptiometry; HUR = hurdlers; LS = lumbar spine; MRI = magnetic resonance imaging; OC = osteocalcin; ORI = orienteers; pQCT = peripheral quantitative computed tomography; RCT = randomized control trial; RUN = runners; SKA = speed skaters; SKI = skiers; SQU = squash players; SWI = swimmers; TRI = triathletes; VOL = volleyball players; WB = whole body; WL = weightlifters.